CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

SHILPA MEDICARE LTD.

NSE : SHILPAMEDBSE : 530549ISIN CODE : INE790G01031Industry : Pharmaceuticals & DrugsHouse : Private
BSE533.30-20.6 (-3.72 %)
PREV CLOSE () 553.90
OPEN PRICE () 556.55
BID PRICE (QTY) 534.45 (7)
OFFER PRICE (QTY) 535.45 (63)
VOLUME 15533
TODAY'S LOW / HIGH ()533.30 556.55
52 WK LOW / HIGH ()228.25 561.15
NSE536.75-17.6 (-3.17 %)
PREV CLOSE() 554.35
OPEN PRICE () 555.90
BID PRICE (QTY) 535.80 (40)
OFFER PRICE (QTY) 536.75 (1)
VOLUME 105416
TODAY'S LOW / HIGH() 532.80 556.00
52 WK LOW / HIGH ()228.5 561.6
ChairmanOmprakash Inani
Managing DirectorVishnukant Bhutada
Company SecretaryRitu Tiwary
Non Executive Independent DirectorHetal Madhukant Gandhi
Arvind Vasudeva
Kamal K Sharma
Anita Bandyopadhyay
Whole Time DirectorSharath Reddy Kalakota
Incorporation Year : 1987

Registered Office :

Address : Shilpa House,#12-6-214/ A1,Hyderabad Road Raichur,
Karnataka-584135 .

Phone : 08532-238704

Email :  info@vbshilpa.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74151.95-459.16 (-0.62%)
NIFTY22573.40-74.80 (-0.33%)
Dow Jones 38225.66322.37 (0.85%)
Nasdaq 15840.96235.48 (1.51%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI